Stonebridge Capital Management’s Exact Sciences EXAS Stock Holding History

Stonebridge Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-13,745	Closed	-$169K	–	135
2016 Q2	$169K	Sell	13,745 -53,865	-80%	-$406K	0.08%	109
2016 Q1	$455K	Buy	67,610 +27,975	+71%	+$179K	0.19%	88
2015 Q4	$366K	Buy	39,635 +17,730	+81%	+$165K	0.15%	112
2015 Q3	$394K	Buy	21,905 +14,075	+180%	+$323K	0.18%	110
2015 Q2	$233K	Buy	+7,830	New	+$197K	0.1%	141
2014 Q4	–	Sell	-19,225	Closed	-$372K	–	185
2014 Q3	$372K	Sell	19,225 -11,605	-38%	-$213K	0.14%	129
2014 Q2	$525K	Buy	+30,830	New	+$424K	0.2%	105

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Stonebridge Capital Management's EXAS Position: Q3 2016 in Review

Stonebridge Capital Management sold out of Exact Sciences (EXAS) in Q3 2016, closing a stake of 13,745 shares — an estimated $169K sold.

Stonebridge Capital Management first reported a position in EXAS in Q2 2014 and held it in 7 quarters. The position peaked at $525K in Q2 2014. 225 funds tracked by Wall St. Rank hold EXAS as of Q3 2016.

Stonebridge Capital Management reported no remaining Exact Sciences position as of Q3 2016 after selling out during the quarter.
Stonebridge Capital Management sold 13,745 Exact Sciences shares in Q3 2016, an estimated $169K.
Stonebridge Capital Management first reported a position in Exact Sciences in Q2 2014 and held it in 7 quarters.
Stonebridge Capital Management's Exact Sciences position peaked at $525K in Q2 2014.
225 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2016.

Based on Stonebridge Capital Management's 13F filing for Q3 2016, filed 17 Oct 2016.